<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Microbiol</journal-id><journal-id journal-id-type="pmc-domain-id">44</journal-id><journal-id journal-id-type="pmc-domain">bmcmicr</journal-id><journal-title-group><journal-title>BMC Microbiology</journal-title></journal-title-group><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10394856</article-id><article-id pub-id-type="pmcid-ver">PMC10394856.1</article-id><article-id pub-id-type="pmcaid">10394856</article-id><article-id pub-id-type="pmcaiid">10394856</article-id><article-id pub-id-type="pmid">37533040</article-id><article-id pub-id-type="doi">10.1186/s12866-023-02957-z</article-id><article-id pub-id-type="publisher-id">2957</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Biofilm stimulating activity of solanidine and Solasodine in <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Noori</surname><given-names initials="HG">Hadi Ghoomdost</given-names></name><address><email>hadi.ghomdostnori@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Tadjrobehkar</surname><given-names initials="O">Omid</given-names></name><address><email>o.tadjrobehkar@kmu.ac.ir</email><email>o.tadjrobehkar@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moazamian</surname><given-names initials="E">Elham</given-names></name><address><email>elhammoazamian@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.449257.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0494 2636</institution-id><institution>Department of Microbiology, College of Sciences, Agriculture and Modern Technology, Shiraz Branch, </institution><institution>Islamic Azad University, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412105.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2092 9755</institution-id><institution>Department of Medical Microbiology (Bacteriology and Virology), Afzalipour Faculty of Medicine, </institution><institution>Kerman University of Medical Sciences, </institution></institution-wrap>Kerman, Iran </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">424975</issue-id><elocation-id>208</elocation-id><history><date date-type="received"><day>27</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>03</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-04 08:25:14.350"><day>04</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12866_2023_Article_2957.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Biofilm formation has reported as an important virulence associated properties of <italic toggle="yes">Pseudomonas aeruginosa</italic> that is regulated by quorum-sensing associated genes. Biofilm and quorum-sensing interfering properties of steroidal alkaloids, Solanidine and Solasodine were investigated in the present study.</p></sec><sec><title>Results</title><p id="Par2">Biofilm formation capacity and relative expression level of five studied genes(<italic toggle="yes">lasI, lasR, rhlI, rhlR</italic> and <italic toggle="yes">algD</italic>) were significantly increased dose-dependently after treatment with sub-inhibitory concentrations (32 and 512&#160;&#181;g/ml) of the both Solanidine and Solasodine. Biofilm formation capacity was more stimulated in weak biofilm formers(9 iaolates) in comparison to the strong biofilm producers(11 isolates). The <italic toggle="yes">lasI</italic> gene was the most induced QS-associated gene among five investigated genes.</p></sec><sec><title>Conclusion</title><p id="Par3">Biofilm inducing properties of the plants alkaloids and probably medicines derived from them has to be considered for revision of therapeutic guidelines. Investigating the biofilm stimulating properties of corticosteroids and other medicines that comes from plant alkaloids also strongly proposed.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>1-Introduction</title><p id="Par4"><italic toggle="yes">Pseudomonas aeruginosa (P. aeruginosa)</italic> is a Gram negative rod which has well known as a pathogen in both plants and animals [<xref ref-type="bibr" rid="CR1">1</xref>]. <italic toggle="yes">P. aeruginosa</italic> is the causative agent of 7.1&#8211;9% of different nosocomial infections especially pneumoniae in in persons with compromised immune system and cystic fibrosis patients [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. <italic toggle="yes">P. aeruginosa</italic> is a multidrug resistant and biofilm former pathogen that classified as one member of the ESKAPE group which have introduced as the causative agents of severe nosocomial infections and major problem on the way to successful eradictional treatment [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Mutations in the genes encoding antibiotic targeted components, acquisition of resistance associated genes from the environment, blocking penetration of antibiotics through structural changes in membrane and cell wall, production of antibiotic destructive enzymes, efflux pumps and finally biofilm formation are the major mechanisms that used by <italic toggle="yes">P. aeruginosa</italic> to resist antibiotic agents [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par5">Biofilm formation is one of the important virulence associated factors that capable <italic toggle="yes">P. aeruginosa</italic> to effectively colonize and survive in the targeted sites. The biofilm matrix of <italic toggle="yes">P. aeruginosa</italic> composed a mixture of extracellular DNA, polysaccharides, proteins and lipids which encompasses the bacteria. This complex matrix protects bacterial cells from the environmental harsh conditions including host immune system, antibacterial agents and chemical warfare of other bacteria [<xref ref-type="bibr" rid="CR6">6</xref>]. Bacterial cells within the biofilm population are synchronized with each other through a signaling network composed of special chemical agents that are known as quorum-sensing (QS) [<xref ref-type="bibr" rid="CR7">7</xref>]. Four QS system were identified in <italic toggle="yes">P. aeruginosa</italic> including LasIR, Iqs, Pqs and RhlIR. All four QS regulons composed of so many genes, transcription of the genes in every QS system is regulated by some chemical autoinducers that are produced exclusively for each system. Las and Rhl are the most important QS systems and N-(3-oxododecanoyl) homoserine lactone and N-butyril homoserine lactone were introduced as the major autoinducer molecules in las and rhl systems respectively [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. QS associated genes also regulate production and release of so many virulence factors other than biofilm formation in <italic toggle="yes">P. aeruginosa</italic> such as pyocyanin, toxins, protease, elastase, motility, ion chelators, efflux pumps and expression of type 6 secretion system(T6SS) effectors [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par6">Disrupting of QS could be beneficial in several ways including inhibition of biofilm formation, virulence associated factors and antibiotic resistance, therefore QS interfering components are regarded as suitable therapeutic candidate [<xref ref-type="bibr" rid="CR11">11</xref>]. In the recent decades, the great volume of studies were conducted to find such agents. In this regards, natural active ingredients of plants were broadly investigated [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>]. Alkaloids are one major group of these agents which are provided by wide range of the plants, marine creatures and some amphibians. Versatile alkaloids are produced by plants as a part of defense mechanisms against pathogens [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par7">Tomatidine, Solanidine (SN) and Solasodine (SS) are alkaloids which produced by <italic toggle="yes">Solanaceae</italic> family plants. The antibacterial, antifungal, antiviral, anticancer, anti-inflammatory and QS interfering properties of Tomatidine were reported formerly [<xref ref-type="bibr" rid="CR19">19</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref>]. We surprisingly detect biofilm stimulating properties from sub-inhibitory concentrations of tomatidine in <italic toggle="yes">P. aeruginosa</italic>, recently [<xref ref-type="bibr" rid="CR24">24</xref>]. But SN and SS were investigated more limited. In the present study we tried to investigate QS interfering properties of sub-inhibitory concentrations of Solanidine and Solasodine and also their effects on biofilm formation ability of <italic toggle="yes">P. aeruginosa.</italic></p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Minimal inhibitory concentration of the SN and SS</title><p id="Par8">No inhibitory properties were detected from the Solanidine and Solasodine at the studied concentrations (125&#8211;2000&#160;&#181;g/mL).</p></sec><sec id="Sec4"><title>Quantitative analysis of biofilm formation</title><p id="Par9">Biofilm formation ability of isolated bacteria were estimated based on the optical density (OD) of mature biofilm at 570&#160;nm obtained from microtiter plate technique. Eleven out of 20 isolates showed an OD value more than four times of the ODc(sterile medium plus 1% glucose as control), these isolates were regarded as strong biofilm producer and 9 isolates have ODc&#8201;&lt;&#8201;OD &lt; )2 &#215; ODc( and introduced as weak biofilm formers.</p></sec><sec id="Sec5"><title>quantitative analysis of biofilm formation after treatment with tobramycin, SN and SS</title><p id="Par10">Biofilm production was reduced significantly(<italic toggle="yes">p</italic>&#8201;=&#8201;0.001) after treatment with 1&#160;&#181;g/ml of tobramycin in comparison to untreated condition. Treatment with two sub-inhibitory concentrations(32&#160;&#181;g/ml and 512&#160;&#181;g/ml) of SN enhanced biofilm formation significantly in comparison to untreated condition in both weak biofilm formers and strong biofilm formers. Similar finding was observed concerning the SS. Treatment of isolates with sub-inhibitory concentrations(32&#160;&#181;g/ml and 512&#160;&#181;g/ml) of solasodine also enhanced biofilm formation significantly(Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Statistical analysis also showed that induction of biofilm formation by the SN and SS is directly dose-dependent and higher concentrations of both studied alkaloids are significantly more potent inducer of biofilm formation in the both group of studied isolates in comparison to the lower concentration(Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par13">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Biofilm inducing power(%) of 1&#160;&#181;g/ml tobramycin and two subinhibitory concentration (32 and 512&#160;&#181;g/ml) of SN and SS in comparison to the untreated condition as the control(red line) in weak biofilm formers and strong biofilm formers. Negative numbers showed biofilm reducing capacity</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e389" position="float" orientation="portrait" xlink:href="12866_2023_2957_Fig2_HTML.jpg"/></fig>
</p><p id="Par12">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Quantitative analysis of biofilm formation (Mean optical density) of weak biofilm producers (9 isolates), strong biofilm producers (11 isolates) and PAO1 strain of <italic toggle="yes">P. aeruginosa</italic> in different treatment conditions. All treatment conditions(tobramycin 1&#160;&#181;g/ml and two concentrations of solanidine and solasodine) were compared with untreated condition as control. *Significant difference (<italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.05) was observed between the mean OD of treatment condition in comparison to untreated conditions</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e407" position="float" orientation="portrait" xlink:href="12866_2023_2957_Fig1_HTML.jpg"/></fig>
</p><p id="Par11">Mathematical analysis showed that treatment with 1&#160;&#181;g/ml tobramycin reduced biofilm formation ability of the weak biofilm formers and strong biofilm formers, 13% and 11% respectively in comparison to the untreated condition. The 32&#160;&#181;g/ml concentration of SN enhanced biofilm formation ability of weak biofilm producers and strong biofilm producers 27.8% and 25.5% respectively, also 101% and 78.3% increased biofilm formation were detected in weak biofilm producers and strong biofilm producers after treatment with 512&#160;&#181;g/ml concentration of SN respectively. Similar phenomenon was detected after treatment with sub-inhibitory concentrations of SS, so that biofilm formation ability of weak biofilm formers and strong biofilm formers enhanced 31.5% and 27.2% after treatment with 32&#181;/ml and 105.3% and 82.7% after treatment with 512&#160;&#181;g/ml concentration of SS respectively(Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). There were not observed significant differences between biofilm inducing power of similar concentration of SN and SS in weak biofilm producers and strong biofilm producers(<italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.05).</p></sec><sec id="Sec101"><title>Relative expression level of biofilm associated genes in untreated condition in comparison to treatment with two sub-inhibitory concentrations of SN and SS</title><p id="Par15">The paired t-test analysis revealed that, the mean expression levels of all five studied genes were increased significantly after treatment with two sub-inhibitory concentrations of SN (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>) and SS (Figs.&#160;<xref rid="Fig4" ref-type="fig">4</xref>) and 512&#160;&#181;g/mL concentration of both studied alkaloids was significantly more powerful inducer in comparison to 32&#160;&#181;g/mL concentration (Figs.&#160;<xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>).</p><p id="Par16">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Relative expression level of five studied genes in untreated condition and in the presence of two sub-inhibitory concentrations (32 and 512&#160;&#181;g/mL) of Solanidine. <bold>*</bold><italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.05</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e449" position="float" orientation="portrait" xlink:href="12866_2023_2957_Fig3_HTML.jpg"/></fig>
</p><p id="Par17">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Relative expression level of five studied genes in untreated condition and in the presence of two sub-inhibitory concentrations (32 and 512&#160;&#181;g/ml) of Solasodine. <bold>*</bold><italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.05</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e466" position="float" orientation="portrait" xlink:href="12866_2023_2957_Fig4_HTML.jpg"/></fig>
</p></sec><sec id="Sec102"><title>Relative expression level of the studied genes in weak biofilm formers in comparison to the strong biofilm formers in different conditions (untreated and two treatment condition)</title><p id="Par19">There was not observed significant differences between relative expression level of the studied genes in weak biofilm formers in comparison to strong biofilm formers after treatment with different concentration of SN and SS, except <italic toggle="yes">rhlR</italic> gene. Statistical analysis revealed that the relative expression level of <italic toggle="yes">rhlR</italic> gene increased significantly in weak biofilm formers in comparison to strong biofilm formers after treatment with 512&#160;&#181;g/ml of Solanidine (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>).</p><p id="Par20">
<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Relative expression level of five desired genes in weak biofilm formers in comparison to strong biofilm producers, after two treatment conditions (32&#160;&#181;g/mL and 512&#160;&#181;g/mL of SN and SS). <bold>*</bold><italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.05</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e497" position="float" orientation="portrait" xlink:href="12866_2023_2957_Fig5_HTML.jpg"/></fig>
</p></sec></sec><sec id="Sec6"><title>Discussion</title><p id="Par21">Antimicrobial properties of different natural products and plant-derived compounds such as alkaloid chemicals were reported in the recent years and they are also available commercially in medicine and traditional medicine [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Although, antibiofilm and QS repressing activity of some herbal product were reported recently [<xref ref-type="bibr" rid="CR26">26</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>]. Dose-dependent biofilm inducing activity of sub-inhibitory concentrations of SN and SS were detected in the present study. Increased expression of some QSs associated genes also have seen in the experiments. Similar dose-dependent stimulation of biofilm formation in different bacterial species after treatment with subinhibitory concentration of antimicrobial agents such as aminoglycosides and fluroquinolones was reported recently [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. This phenomenon referred as Hormesis and liberation of biofilm structural blocks from the death cells and also development of stress responses against sub-inhibitory concentration of antimicrobial were hypothesized as the describing reasons [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par22">In this study, we don&#8217;t detect any inhibitory properties from SN and SS until 2000&#160;&#181;g/mL concentration. While, antibacterial properties of some solanum alkaloids such as tomatidine and solasodine were reported against Gram-positive bacteria such as <italic toggle="yes">Staphylococcus aureus</italic>( <italic toggle="yes">S. aureus</italic>), <italic toggle="yes">Bacillus</italic> species and <italic toggle="yes">Listeria</italic> recently [<xref ref-type="bibr" rid="CR20">20</xref>], Chagnon et al. were reported, medium activity of tomatidine(MIC&#8201;&gt;&#8201;64&#160;&#181;g/ml) against <italic toggle="yes">S. aureus</italic> but, they can&#8217;t detect any inhibitory properties from solanidine analogues. They also suggested that, spatial structure of the solanum molecule and specific orientation of active moieties have decisive role in their antibacterial properties, but no inhibitory activity from tomatidine and solasodine against small colony variant of <italic toggle="yes">S. aureus</italic> were detected [<xref ref-type="bibr" rid="CR34">34</xref>]. The small colony variants are major bacterial morphology within biofilm [<xref ref-type="bibr" rid="CR35">35</xref>]. In contrary, heavy antibacterial activity of tomatidine against small colony variant of <italic toggle="yes">S. aureus</italic> was reported by Boulet et al [<xref ref-type="bibr" rid="CR19">19</xref>]. Thus, different spatial structure of different alkaloid molecules could be the main reason of different antibacterial potential of some alkaloid agents in comparison to the others.</p><p id="Par23">Weak permeability of the Gram-negative bacteria due to the outer membrane layer and richer pool of the antimicrobial resistance mechanisms in Gram negatives such as <italic toggle="yes">P. aeruginosa</italic> in comparison to many Gram positives could explained less effectiveness of solanum molecules against them.</p><p id="Par24"><italic toggle="yes">P. aeruginosa</italic> is usually known as an opportunistic pathogen for both plants and animals. But, some beneficial properties of this pathogen for plants; including promoting plant growth through antagonistic action against some bacterial and fungal phytopathogens and also promoting colonization of beneficial species were reported recently and critical leadership role of the QS systems especially LasIR and RhlIR have revealed in this process [<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, secretion of some QS-inducing substances such as solanum chemicals or other alkaloids could be regarded as a plant inducing signal that enhanced expression of QS associated genes, biofilm formation and subsequently successful colonization of the beneficial bacteria. Our finding strongly supports this hypothesis.</p><p id="Par25">The ATP synthase was introduced as the main target of tomatidine in <italic toggle="yes">S. aureus</italic> recently [<xref ref-type="bibr" rid="CR19">19</xref>]. Therefore, different structure of bacterial targets such as ATP synthase in Gram positive and Gram negatives could be hypothesized as another reason. Ineffectiveness of some new antibiotics that knockdown ATP synthase in Gram positives, against Gram negatives was reported recently and support this hypothesis [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par26">Biofilm inhibiting properties of 1&#160;&#181;g/ml tobramycin was detected in our study. Tobramycin also was reported as a biofilm reducing agent in other studies [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Both SN and SS enhanced biofilm formation ability of <italic toggle="yes">P. aeruginosa</italic> isolates. Our finding showed that biofilm inducing properties of SN and SS was directly dose dependent and also both studied alkaloids were considered stronger biofilm inducer in weak biofilm producers in comparison to the strong biofilm producers(Figs.&#160;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig1" ref-type="fig">1</xref>). We believe that strong biofilm producers have obtained heavy biofilm production ability and paid costs such as reduced competition characteristics, reduced virulence and probably irritability from environmental stresses, this phenomenon well reported as fitness cost in some recent studies [<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par27">The expression of all five investigated genes were increased significantly after treatment with both sub-inhibitory concentrations of SN and SS. The 512&#160;&#181;g/ml concentration of both studied alkaloid were more potent inducer in comparison to the 32&#160;&#181;g/ml concentration that support direct dose dependent inducing properties of solanum molecules. The <italic toggle="yes">lasI</italic> gene was the most induced gene by both SN and SS(Figs.&#160;<xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). Therefore. It seems that the LasIR system is more important for biofilm formation in comparison to the RhlIR system as this is reported formerly in another study [<xref ref-type="bibr" rid="CR41">41</xref>]. Regulation of RhlIR system by LasIR system and superiority of LasIR system over RhlIR system also reported formerly [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par28">Our finding revealed that the <italic toggle="yes">algD</italic> and <italic toggle="yes">rhlR</italic> were the least induced genes among the five studied genes. Statistical analysis also revealed that, the <italic toggle="yes">rhlR</italic> gene was significantly less expressed in weak biofilm producers in comparison to the strong biofilm producers after treatment with 512&#160;&#181;g/ml Solanidine (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>). Some other studies hypothesized that the RhlR in contrary to LasR is a major in vivo receptor that repress expression of some Qs associated virulence factors [<xref ref-type="bibr" rid="CR42">42</xref>]. Thus, less involvement of <italic toggle="yes">rhlR</italic> gene in biofilm formation process and inducing QS associated mechanisms could be concluded.</p><p id="Par29">Steroidal alkaloids derived from <italic toggle="yes">Solanaceae</italic> family such as Solasodine are employed as drug precursors in manufacturing many different storied drugs such as corticosteroids, antifertility drugs and steroid anabolic steroids [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. We also find some recent papers that reporting abolishment of antibacterial and antibiofilm activity of some antibiotic agents by anti-inflammatory corticosteroid drugs [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Increased rate of treatment failure in combination therapy with antibiotics and corticosteroids also has reported previously [<xref ref-type="bibr" rid="CR47">47</xref>]. Therefore, biofilm inducing properties of solanum alkaloids that was detected in the present study remind a warning about the same properties of solanum derived commercial drugs. Therefore, we propose to studying the biofilm inducing properties of such drugs specially in <italic toggle="yes">invivo</italic> condition and we believe that the acquired results could be beneficial and useful in revision of therapeutic prescriptions especially in biofilm associated infections and also therapy regiments containing combination therapy with antimicrobial agents and plant derived steroid drugs.</p></sec><sec id="Sec7"><title>Conclusion</title><p id="Par30">Sub-inhibitory concentration of Solanidine and Solasodine stimulated biofilm formation in <italic toggle="yes">P. aeruginosa</italic> in a dose-dependent manner. They also have increased expression of LasIR and RhlIR QS associated genes vigorously. Biofilm inducing properties of the steroidal Phytoalkaloids and probably medicines derived from them has to be considered in development of new therapeutic regiments and also revision of existed guidelines. But, investigating the biofilm stimulating properties of corticosteroids and other medicines that comes from plant alkaloids on a larger group of different bacterial species is necessary to reach confirmation. Finally, we also believe that sub-inhibitory of solanum alkaloids could be used usefully in research field in direction to stimulate biofilm formation of the bacteria in culture media.</p></sec><sec id="Sec8"><title>Material and methods</title><sec id="Sec9"><title>Bacterial isolates and phenotypic detection of biofilm formation</title><p id="Par31">Twenty local isolates of <italic toggle="yes">P. aeruginosa</italic> were used in all assessments. Bacterial isolates were obtained from different clinical samples in a recent study [<xref ref-type="bibr" rid="CR24">24</xref>]. PaO1 strain also was used in all experiments as a strong biofilm former control. Biofilm formation ability of the isolates was confirmed by microtiter plate method through detection the optical density of safranin-stained sessile bacteria on the bottom and the walls of the polystyrene wells at 570&#160;nm. Biofilm former isolates were grouped as strong biofilm formers and weak biofilm formers according to the Stepanovic et al. method [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. All experiment were repeated in triplicate and investigated bacteria were preserved in -70&#160;&#176;C until use.</p></sec><sec id="Sec10"><title>Evaluation the minimum inhibitory concentration (MIC) of SN, SS and tobramycin</title><p id="Par32">Broth microdilution method was used for evaluation the MIC of SN, SS( 125 to 2048 <sub>&#181;g/ml</sub>, 1/2 serial dilution concentrations of both studied alkaloids were investigated) and tobramycin according to the CLSI guidelines [<xref ref-type="bibr" rid="CR50">50</xref>]. MIC range of tobramycin among different isolates was 2&#8211;64 <sub>&#181;g/ml</sub>. Therefor, 1 <sub>&#181;g/ml</sub> of tobramycin was used as control in the biofilm formation assessments.</p></sec><sec id="Sec11"><title>Investigation of the biofilm formation after treatment with tobramycin, SN and SS</title><p id="Par33">Evaluation of the biofilm formation capacity of the studied isolates in the absence/presence of the subinhibitory concentration of SS, SN and tobramycin as control was the main goal. Therefore, all of the isolates were treated with the compounds at the start point of the experiment in the microplate wells. Biofilm formation ability of the studied isolates was investigated quantitively after treatment with 1&#160;&#181;g/ml of tobramycin and two concentration (32 and 512&#160;&#181;g/ml) of SN and SS in comparison to untreated condition. Mean optical density (OD) of resuspended stained mature biofilms at 570&#160;nm was used in order to quantitative estimation of biofilm formation capacity of isolates(26).</p></sec><sec id="Sec12"><title>Evaluation the relative expression level of investigated genes (lasI, lasR, rhlI, rhlR and algD)</title><p id="Par34">Quantitative real-time PCR (qPCR) was performed in order to evaluating relative expression level of investigated genes. Briefly, all studied bacteria were cultured in Luria-Bertani broth (Merck, Germany) in untreated and different treatment conditions as mentioned before, and incubated overnight at 37&#160;&#176;C. RNA was extracted from overnight cultures by RNA isolation kit (Dena-Zist, Iran). Purity and stability of the extracted RNAs was confirmed by calculation of the 260&#160;nm/280 nm OD ratio of suspensions and electrophoresis on 1% agarose gel, respectively. The Viva 2-step RT-PCR kit (Vivantis, Malaysia) with Syber-Green master mix technology was used in synthesis of cDNA and amplification process. Step one plus Real-time PCR system (Marsiling industries, Singapore) and specific primers (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>) were used in qPCR amplification. The <italic toggle="yes">gyrA</italic> gene was used as internal reference gene [<xref ref-type="bibr" rid="CR21">21</xref>]. The comparative CT method was used in calculation of the relative expression level (2<sup>&#8722;&#916;CT</sup>) of the investigated genes in untreated and after different treatment conditions [<xref ref-type="bibr" rid="CR51">51</xref>].</p><p id="Par35">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>List of the primers that were used in qPCR amplification process</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Name</th><th align="left" colspan="1" rowspan="1">Forward primer (5&#8217;&#8211;3&#8217;)</th><th align="left" colspan="1" rowspan="1">Reverse primer (5&#8217;&#8211;3&#8217;)</th><th align="left" colspan="1" rowspan="1">Amplicon length (bp)</th><th align="left" colspan="1" rowspan="1">Tm (&#186;C)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">lasI</italic>
</td><td align="left" colspan="1" rowspan="1">CTTTTCCGACTGTACGCT</td><td align="left" colspan="1" rowspan="1">ATCATCTTCTCCACGCCT</td><td align="left" colspan="1" rowspan="1">108</td><td align="left" colspan="1" rowspan="1">57</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">lasR</italic>
</td><td align="left" colspan="1" rowspan="1">CTTGGTTGACGGTTTTCT</td><td align="left" colspan="1" rowspan="1">CTCCACTCCAATTTTCCAC</td><td align="left" colspan="1" rowspan="1">54</td><td align="left" colspan="1" rowspan="1">57</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">rhlI</italic>
</td><td align="left" colspan="1" rowspan="1">CAAACCCGCTACATCGTC</td><td align="left" colspan="1" rowspan="1">TGCACAGGTAGGCGAAGA</td><td align="left" colspan="1" rowspan="1">109</td><td align="left" colspan="1" rowspan="1">56</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">rhlR</italic>
</td><td align="left" colspan="1" rowspan="1">GAGGCTTTTTGCTGTGGT</td><td align="left" colspan="1" rowspan="1">GGGTGAAGGGAATCGTGT</td><td align="left" colspan="1" rowspan="1">105</td><td align="left" colspan="1" rowspan="1">56</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">algD</italic>
</td><td align="left" colspan="1" rowspan="1">GGGGCCAACAAGGAATACA</td><td align="left" colspan="1" rowspan="1">AGCACCAGCACATCGGAA</td><td align="left" colspan="1" rowspan="1">101</td><td align="left" colspan="1" rowspan="1">57</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">gyrA</italic>
</td><td align="left" colspan="1" rowspan="1">ACACCGAGGCGAACAAGA</td><td align="left" colspan="1" rowspan="1">TAGTCGGTGGTGAGGAAGT</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">57</td></tr></tbody></table><table-wrap-foot><p>The specificity of the primers was evaluated by melt curves</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec13"><title>Statistical analysis</title><p id="Par37">Statistical product and service solution (SPSS) software version 26 was used in data analysis. Mean OD of both groups of isolates(weak biofilm formers and strong biofilm formers) was compared in different treatment condition with untreated condition and with each other through analysis of variance (ANOVA). The mean expression level of investigated genes in untreated condition was compared with the same values in different treatment conditions by paired t-test analysis. The <italic toggle="yes">p</italic>-value&#8201;&#8804;&#8201;0.05 was regarded as significant.</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful for the kindly cooperation of the medical school laboratory staff of Kerman University of medical sciences.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>OT introduced the primary idea.OT and EM were involved designing the study. Resources were provided by HGN and OT. HGN collected the bacterial isolates. OT, EM and HGN had equal roles in designing and implementation of the actual steps of methods. Statistical analysis and interpretations were done by OT. The primary version of the manuscript was prepared by OT, but, it was revised and completed by OT, EM and HGN. The submitted version of this manuscript was also read and accepted by OT, EM and HGN.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This project was approved by Vice-Chancellor for Research and Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran, but no fund was provided for practical steps and even publication and all of the funds were provided by HGN and OT(the authors). Data collection, analysis and interpretation were conducted by the authors and no one else has been involved. Manuscript also prepared and revised by the authors.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes><title>Ethics approval and consent to participate</title><p>Obtaining consent to participate <underline>is not applicable</underline> for this study because our isolates were collected during a recent study from existing clinical collections routinely assembled as part of laboratory practices(we used the stored samples that were preserved in -70&#160;&#176;C) and human or animals were not participated as sample source.</p></notes><notes><title>Consent for publication</title><p>Not applicable.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par38">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term><italic toggle="yes">P. aeruginosa</italic></term><def><p id="Par39">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</p></def></def-item><def-item><term>QS</term><def><p id="Par40">Quorum-sensing</p></def></def-item><def-item><term>SN</term><def><p id="Par41">Solanidine</p></def></def-item><def-item><term>SS</term><def><p id="Par42">Solasodine</p></def></def-item><def-item><term>T6SS</term><def><p id="Par43">Type 6 secretion system</p></def></def-item><def-item><term>OD</term><def><p id="Par44">Optical density</p></def></def-item><def-item><term>MIC</term><def><p id="Par45">Minimum inhibitory concentration</p></def></def-item><def-item><term>qPCR</term><def><p id="Par46">Quantitative real-time PCR</p></def></def-item><def-item><term>SPSS</term><def><p id="Par47">Statistical product and service solution software</p></def></def-item><def-item><term>ANOVA</term><def><p id="Par48">Analysis of variance</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azam</surname><given-names>MW</given-names></name><name name-style="western"><surname>Khan</surname><given-names>AU</given-names></name></person-group><article-title>Updates on the pathogenicity status of Pseudomonas aeruginosa</article-title><source>Drug Discov Today</source><year>2019</year><volume>24</volume><issue>1</issue><fpage>350</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2018.07.003</pub-id><pub-id pub-id-type="pmid">30036575</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>D</given-names></name><name name-style="western"><surname>Kollef</surname><given-names>M</given-names></name></person-group><article-title>The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa Infections: an update</article-title><source>Drugs</source><year>2021</year><volume>81</volume><issue>18</issue><fpage>2117</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s40265-021-01635-6</pub-id><pub-id pub-id-type="pmid">34743315</pub-id><pub-id pub-id-type="pmcid">PMC8572145</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics</article-title><source>Signal Transduct Target Ther</source><year>2022</year><volume>7</volume><issue>1</issue><fpage>199</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01056-1</pub-id><pub-id pub-id-type="pmid">35752612</pub-id><pub-id pub-id-type="pmcid">PMC9233671</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sionov</surname><given-names>RV</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>D</given-names></name></person-group><article-title>Targeting the Holy Triangle of Quorum Sensing, Biofilm formation, and Antibiotic Resistance in pathogenic Bacteria</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><issue>6</issue><fpage>1239</fpage><pub-id pub-id-type="doi">10.3390/microorganisms10061239</pub-id><pub-id pub-id-type="pmid">35744757</pub-id><pub-id pub-id-type="pmcid">PMC9228545</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jangra</surname><given-names>V</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>N</given-names></name><name name-style="western"><surname>Chhillar</surname><given-names>AK</given-names></name></person-group><article-title>Therapeutic approaches for combating Pseudomonas aeruginosa infections</article-title><source>Microbes Infect</source><year>2022</year><volume>24</volume><issue>4</issue><fpage>104950</fpage><pub-id pub-id-type="doi">10.1016/j.micinf.2022.104950</pub-id><pub-id pub-id-type="pmid">35139390</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>del Mar Cendra</surname><given-names>M</given-names></name><name name-style="western"><surname>Torrents</surname><given-names>E</given-names></name></person-group><article-title>Pseudomonas aeruginosa biofilms and their partners in crime</article-title><source>Biotechnol adv</source><year>2021</year><volume>49</volume><fpage>107734</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2021.107734</pub-id><pub-id pub-id-type="pmid">33785375</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antunes</surname><given-names>LCM</given-names></name><etal/></person-group><article-title>Quorum sensing in bacterial virulence</article-title><source>Microbiol (Reading)</source><year>2010</year><volume>156</volume><issue>Pt 8</issue><fpage>2271</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1099/mic.0.038794-0</pub-id><pub-id pub-id-type="pmid">20488878</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>The hierarchy quorum sensing network in Pseudomonas aeruginosa</article-title><source>Protein Cell</source><year>2015</year><volume>6</volume><issue>1</issue><fpage>26</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/s13238-014-0100-x</pub-id><pub-id pub-id-type="pmid">25249263</pub-id><pub-id pub-id-type="pmcid">PMC4286720</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaber</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa</article-title><source>J Med Microbiol</source><year>2004</year><volume>53</volume><issue>9</issue><fpage>841</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.45617-0</pub-id><pub-id pub-id-type="pmid">15314190</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kostylev</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evolution of the Pseudomonas aeruginosa quorum-sensing hierarchy</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><issue>14</issue><fpage>7027</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1073/pnas.1819796116</pub-id><pub-id pub-id-type="pmid">30850547</pub-id><pub-id pub-id-type="pmcid">PMC6452656</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scoffone</surname><given-names>VC</given-names></name><etal/></person-group><article-title>Quorum sensing as antivirulence target in cystic fibrosis pathogens</article-title><source>Int J Mol Sci</source><year>2019</year><volume>20</volume><issue>8</issue><fpage>1838</fpage><pub-id pub-id-type="doi">10.3390/ijms20081838</pub-id><pub-id pub-id-type="pmid">31013936</pub-id><pub-id pub-id-type="pmcid">PMC6515091</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>S</given-names></name><etal/></person-group><article-title>Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors</article-title><source>Appl Microbiol Biotechnol</source><year>2019</year><volume>103</volume><issue>8</issue><fpage>3521</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-09618-0</pub-id><pub-id pub-id-type="pmid">30852658</pub-id><pub-id pub-id-type="pmcid">PMC6449319</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asfour</surname><given-names>HZ</given-names></name></person-group><article-title>Anti-Quorum Sensing Natural Compounds</article-title><source>J Microsc Ultrastruct</source><year>2018</year><volume>6</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.4103/JMAU.JMAU_10_18</pub-id><pub-id pub-id-type="pmid">30023261</pub-id><pub-id pub-id-type="pmcid">PMC6014249</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cushnie</surname><given-names>TP</given-names></name><name name-style="western"><surname>Cushnie</surname><given-names>B</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>AJ</given-names></name></person-group><article-title>Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities</article-title><source>Int J Antimicrob Agents</source><year>2014</year><volume>44</volume><issue>5</issue><fpage>377</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2014.06.001</pub-id><pub-id pub-id-type="pmid">25130096</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Defoirdt</surname><given-names>T</given-names></name></person-group><article-title>Quorum-sensing Systems as targets for Antivirulence Therapy</article-title><source>Trends Microbiol</source><year>2018</year><volume>26</volume><issue>4</issue><fpage>313</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2017.10.005</pub-id><pub-id pub-id-type="pmid">29132819</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalaiarasan</surname><given-names>E</given-names></name><etal/></person-group><article-title>Inhibition of quorum sensing-controlled biofilm formation in Pseudomonas aeruginosa by quorum-sensing inhibitors</article-title><source>Microb Pathog</source><year>2017</year><volume>111</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.08.017</pub-id><pub-id pub-id-type="pmid">28818490</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajkumari</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cinnamic acid attenuates quorum sensing associated virulence factors and biofilm formation in Pseudomonas aeruginosa PAO1</article-title><source>Biotechnol Lett</source><year>2018</year><volume>40</volume><issue>7</issue><fpage>1087</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1007/s10529-018-2557-9</pub-id><pub-id pub-id-type="pmid">29680931</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindequist</surname><given-names>U</given-names></name></person-group><article-title>Marine-derived pharmaceuticals&#8211;challenges and opportunities</article-title><source>Biomol Ther</source><year>2016</year><volume>24</volume><issue>6</issue><fpage>561</fpage><pub-id pub-id-type="doi">10.4062/biomolther.2016.181</pub-id><pub-id pub-id-type="pmcid">PMC5098534</pub-id><pub-id pub-id-type="pmid">27795450</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Lamontagne Boulet M, et al. Tomatidine is a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C. Antimicrob Agents Chemother. 2018;62(6). 10.1128/AAC.02197-17.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.02197-17</pub-id><pub-id pub-id-type="pmcid">PMC5971568</pub-id><pub-id pub-id-type="pmid">29610201</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guay</surname><given-names>I</given-names></name><etal/></person-group><article-title>Tomatidine and analog FC04-100 possess bactericidal activities against Listeria, Bacillus and Staphylococcus spp</article-title><source>BMC Pharmacol Toxicol</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s40360-018-0197-2</pub-id><pub-id pub-id-type="pmid">29439722</pub-id><pub-id pub-id-type="pmcid">PMC5812199</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>G</given-names></name><etal/></person-group><article-title>Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression</article-title><source>J Antimicrob Chemother</source><year>2012</year><volume>67</volume><issue>3</issue><fpage>559</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1093/jac/dkr510</pub-id><pub-id pub-id-type="pmid">22129590</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Troost</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41598-020-63397-7</pub-id><pub-id pub-id-type="pmid">32286447</pub-id><pub-id pub-id-type="pmcid">PMC7156627</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dey</surname><given-names>P</given-names></name><etal/></person-group><article-title>Therapeutic value of steroidal alkaloids in cancer: current trends and future perspectives</article-title><source>Int J Cancer</source><year>2019</year><volume>145</volume><issue>7</issue><fpage>1731</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1002/ijc.31965</pub-id><pub-id pub-id-type="pmid">30387881</pub-id><pub-id pub-id-type="pmcid">PMC6767045</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noori</surname><given-names>HG</given-names></name><name name-style="western"><surname>Tadjrobehkar</surname><given-names>O</given-names></name><name name-style="western"><surname>Moazamian</surname><given-names>E</given-names></name></person-group><article-title>Biofilm formation capacity of Pseudomonas aeruginosa is significantly enhanced by sub-inhibitory concentrations of Tomatidine</article-title><source>Gene Rep</source><year>2022</year><volume>27</volume><fpage>101570</fpage><pub-id pub-id-type="doi">10.1016/j.genrep.2022.101570</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khameneh</surname><given-names>B</given-names></name><etal/></person-group><article-title>Review on plant antimicrobials: a mechanistic viewpoint</article-title><source>Antimicrob Resist Infect Control</source><year>2019</year><volume>8</volume><issue>1</issue><fpage>118</fpage><pub-id pub-id-type="doi">10.1186/s13756-019-0559-6</pub-id><pub-id pub-id-type="pmid">31346459</pub-id><pub-id pub-id-type="pmcid">PMC6636059</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Eugenol: a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><issue>3</issue><fpage>e0119564</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0119564</pub-id><pub-id pub-id-type="pmid">25781975</pub-id><pub-id pub-id-type="pmcid">PMC4364371</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathinam</surname><given-names>P</given-names></name><name name-style="western"><surname>Vijay Kumar</surname><given-names>HS</given-names></name><name name-style="western"><surname>Viswanathan</surname><given-names>P</given-names></name></person-group><article-title>Eugenol exhibits anti-virulence properties by competitively binding to quorum sensing receptors</article-title><source>Biofouling</source><year>2017</year><volume>33</volume><issue>8</issue><fpage>624</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1080/08927014.2017.1350655</pub-id><pub-id pub-id-type="pmid">28792229</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Shabib</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Eugenol inhibits quorum sensing and biofilm of toxigenic MRSA strains isolated from food handlers employed in Saudi Arabia</article-title><source>Biotechnol Biotechnol Equip</source><year>2017</year><volume>31</volume><issue>2</issue><fpage>387</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1080/13102818.2017.1281761</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>AA</given-names></name><name name-style="western"><surname>Salih</surname><given-names>FA</given-names></name></person-group><article-title>Quercus infectoria gall extracts reduce quorum sensing-controlled virulence factors production and biofilm formation in Pseudomonas aeruginosa recovered from burn wounds</article-title><source>BMC Complement Altern Med</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>177</fpage><pub-id pub-id-type="doi">10.1186/s12906-019-2594-5</pub-id><pub-id pub-id-type="pmid">31319827</pub-id><pub-id pub-id-type="pmcid">PMC6639949</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hnamte</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mosloflavone attenuates the quorum sensing controlled virulence phenotypes and biofilm formation in Pseudomonas aeruginosa PAO1: in vitro, in vivo and in silico approach</article-title><source>Microb Pathog</source><year>2019</year><volume>131</volume><fpage>128</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2019.04.005</pub-id><pub-id pub-id-type="pmid">30959097</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaplan</surname><given-names>JB</given-names></name></person-group><article-title>Antibiotic-induced biofilm formation</article-title><source>Int J Artif Organs</source><year>2011</year><volume>34</volume><issue>9</issue><fpage>737</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.5301/ijao.5000027</pub-id><pub-id pub-id-type="pmid">22094552</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rafaque</surname><given-names>Z</given-names></name><etal/></person-group><article-title>In-vitro investigation of antibiotics efficacy against uropathogenic Escherichia coli biofilms and antibiotic induced biofilm formation at sub-minimum inhibitory concentration of ciprofloxacin</article-title><source>Infect Drug Resist</source><year>2020</year><volume>13</volume><fpage>2801</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.2147/IDR.S258355</pub-id><pub-id pub-id-type="pmid">32848429</pub-id><pub-id pub-id-type="pmcid">PMC7429215</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ranieri</surname><given-names>MR</given-names></name><name name-style="western"><surname>Whitchurch</surname><given-names>CB</given-names></name><name name-style="western"><surname>Burrows</surname><given-names>LL</given-names></name></person-group><article-title>Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials</article-title><source>Curr Opin Microbiol</source><year>2018</year><volume>45</volume><fpage>164</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2018.07.006</pub-id><pub-id pub-id-type="pmid">30053750</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chagnon</surname><given-names>F</given-names></name><etal/></person-group><article-title>Unraveling the structure&#8211;activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus</article-title><source>Eur J Med Chem</source><year>2014</year><volume>80</volume><fpage>605</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2013.11.019</pub-id><pub-id pub-id-type="pmid">24877760</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Mitchell G et al. <italic toggle="yes">Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2i&gt;-heptylquinoline-N-oxide</italic>. BMC Microbiol 2010. 10(1): p.&#160;33. .<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2180-10-33</pub-id><pub-id pub-id-type="pmcid">PMC2824698</pub-id><pub-id pub-id-type="pmid">20113519</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steindler</surname><given-names>L</given-names></name><etal/></person-group><article-title>LasI/R and RhlI/R quorum sensing in a strain of Pseudomonas aeruginosa beneficial to plants</article-title><source>Appl Environ Microbiol</source><year>2009</year><volume>75</volume><issue>15</issue><fpage>5131</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1128/AEM.02914-08</pub-id><pub-id pub-id-type="pmid">19525275</pub-id><pub-id pub-id-type="pmcid">PMC2725484</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balemans</surname><given-names>W</given-names></name><etal/></person-group><article-title>Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><issue>8</issue><fpage>4131</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1128/AAC.00273-12</pub-id><pub-id pub-id-type="pmid">22615276</pub-id><pub-id pub-id-type="pmcid">PMC3421580</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><etal/></person-group><article-title>Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm</article-title><source>Antimicrob Agents Chemother</source><year>2008</year><volume>52</volume><issue>4</issue><fpage>1446</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1128/AAC.00054-07</pub-id><pub-id pub-id-type="pmid">18195062</pub-id><pub-id pub-id-type="pmcid">PMC2292569</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>J</given-names></name><etal/></person-group><article-title>Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin compared to Tobramycin in Pseudomonas aeruginosa Biofilms</article-title><source>Mol Pharm</source><year>2015</year><volume>12</volume><issue>5</issue><fpage>1544</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1021/mp500846u</pub-id><pub-id pub-id-type="pmid">25793309</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morgan</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Bacterial fitness in chronic wounds appears to be mediated by the capacity for high-density growth, not virulence or biofilm functions</article-title><source>PLoS Pathog</source><year>2019</year><volume>15</volume><issue>3</issue><fpage>e1007511</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1007511</pub-id><pub-id pub-id-type="pmid">30893371</pub-id><pub-id pub-id-type="pmcid">PMC6448920</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Kievit</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns</article-title><source>Appl Environ Microbiol</source><year>2001</year><volume>67</volume><issue>4</issue><fpage>1865</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1128/AEM.67.4.1865-1873.2001</pub-id><pub-id pub-id-type="pmid">11282644</pub-id><pub-id pub-id-type="pmcid">PMC92808</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Loughlin</surname><given-names>CT</given-names></name><etal/></person-group><article-title>A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><issue>44</issue><fpage>17981</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.1316981110</pub-id><pub-id pub-id-type="pmid">24143808</pub-id><pub-id pub-id-type="pmcid">PMC3816427</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Solasodine: a perspective on their roles in Health and Disease</article-title><source>J Pharm and Tech</source><year>2019</year><volume>12</volume><issue>5</issue><fpage>2571</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.5958/0974-360X.2019.00432.3</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>P</given-names></name><etal/></person-group><article-title>Updates on steroidal alkaloids and glycoalkaloids in Solanum spp.: biosynthesis, in vitro production and pharmacological values</article-title><source>Stud Nat Prod</source><year>2021</year><volume>69</volume><fpage>99</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-819487-4.00012-4</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa</article-title><source>J Adv Res</source><year>2017</year><volume>8</volume><issue>1</issue><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2016.12.001</pub-id><pub-id pub-id-type="pmid">28053782</pub-id><pub-id pub-id-type="pmcid">PMC5198789</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reidl</surname><given-names>J</given-names></name><name name-style="western"><surname>E.J.E.M</surname><given-names>M</given-names></name><name name-style="western"><surname>Mons&#243;</surname></name></person-group><article-title>Glucocorticoids and antibiotics, how do they get together?</article-title><source>EMBO Mol Med</source><year>2015</year><volume>7</volume><issue>8</issue><fpage>992</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.15252/emmm.201505336</pub-id><pub-id pub-id-type="pmid">26077592</pub-id><pub-id pub-id-type="pmcid">PMC4551337</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Cabellos C et al. <italic toggle="yes">Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis</italic> J Antimicrob Chemother, 2000. 45(3): p.&#160;315 &#8211; 20.DOI: 10.1093/jac/45.3.315.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/45.3.315</pub-id><pub-id pub-id-type="pmid">10702550</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stepanovi&#263;</surname><given-names>S</given-names></name><etal/></person-group><article-title>Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci</article-title><source>APMIS</source><year>2007</year><volume>115</volume><issue>8</issue><fpage>891</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0463.2007.apm_630.x</pub-id><pub-id pub-id-type="pmid">17696944</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">K&#305;rmusao&#287;lu S. <italic toggle="yes">The methods for detection of biofilm and screening antibiofilm activity of agents</italic>, in <italic toggle="yes">Antimicrobials, antibiotic resistance, antibiofilm strategies and activity methods</italic>, S. K&#305;rmusao&#287;lu, Editor. 2019, IntechOpen. p.&#160;1&#8211;17.DOI: 10.5772/intechopen.8441.</mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Wikler M. <italic toggle="yes">Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically</italic> Approved Standard 10th ed. M07-A11, 2018.</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmittgen</surname><given-names>TD</given-names></name><name name-style="western"><surname>Livak</surname><given-names>KJ</given-names></name></person-group><article-title>Analyzing real-time PCR data by the comparative C(T) method</article-title><source>Nat Protoc</source><year>2008</year><volume>3</volume><issue>6</issue><fpage>1101</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.73</pub-id><pub-id pub-id-type="pmid">18546601</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>